SNN

Smith & Nephew plc
D

SNN

29.370
USD
-0.74
(-2.46%)
مغلق
حجم التداول
28,150
الربح لكل سهم
2
العائد الربحي
2.55
P/E
31
حجم السوق
12,850,040,730
أصول ذات صلة
ABT
ABT
-0.770
(-0.56%)
135.620 USD
BAX
BAX
-0.760
(-2.42%)
30.610 USD
BDX
BDX
-2.215
(-1.27%)
172.245 USD
BSX
BSX
1.190
(1.21%)
99.750 USD
EW
EW
-0.720
(-0.95%)
75.170 USD
ILMN
ILMN
-1.120
(-1.27%)
87.000 USD
ISRG
ISRG
-0.86
(-0.17%)
511.99 USD
MDT
MDT
-1.240
(-1.40%)
87.270 USD
PODD
PODD
0.89
(0.29%)
304.58 USD
TMO
TMO
-12.61
(-3.04%)
402.69 USD
المزيد
الأخبار المقالات

العنوان: Smith & Nephew plc

القطاع: Healthcare
الصناعة: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.